LABU : Direxion Daily S&P Biotech Bull 3X Shares

LABU is a Alternative Market Leveraged Equities with MODERATE fees.

LABU

Direxion Daily S&P Biotech Bull 3X Shares

FI Score

47 /100

Expense Ratio Rating

6 /10

Expense Rating

0 /10

Market Score

9 /10

Category Score

0 /10

Market Size

9 /10

47% FI Score
  • labu
  • ETF
  • Alternative
  • Leveraged Equities

Direxion Daily S&P Biotech Bull 3X Shares

Expenses: 1.04% (Better than 1% of similar funds)

This is a bad choice for a Leveraged Equities Alternative fund. See why ยป

Fund Summary

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index (index). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds (ETFs) that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Largest Holdings

Amount Holding
6.73% S&P Biotechnology Select Industry USD
5.69% S&P Biotechnology Select
1.27% Future on S&P Biotechnology Select Industry USD Dec49
0.94% Mirati Therapeutics Inc
0.87% Exact Sciences Corp
0.86% Biomarin Pharmaceutical Inc
0.85% Global Blood Therapeutics Inc
0.85% Intercept Pharmaceuticals Inc
0.83% Amgen Inc
0.83% The Medicines Co

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo